Day: April 23, 2024

BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)

FendX Advancing REPELWRAP(TM) Film with Dunmore by Conducting an Additional Pilot Manufacturing Run on Dunmore’s Commercial Manufacturing Line and Provides Corporate Update

Oakville, Ontario--(Newsfile Corp. - April 23, 2024) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...

error: Content is protected !!